FDA recall, , High risk
Vitruvias Therapeutics Thyroid Tablets
Thyroid Tablets, USP are superpotent and can cause hyperthyroidism.
Summary by Recall Canary from the FDA notice
What happened
Vitruvias Therapeutics Inc., of Auburn, Alabama, is recalling Thyroid Tablets, USP, 1/2 Grain (30 mg), each tablet containing levothyroxine (T4) 19 mcg and liothyronine (T3) 4.5 mcg, because testing showed an upward T3 assay trend, and the product is potentially superpotent. The recall was initiated and announced on August 21, 2026, and added to the FDA's Enforcement Report on September 11, 2026.
The product, distributed nationwide in the US, is packaged as 100 tablets. The recall covers 1955 bottles.
What to do
If a code on your package is listed below:
- Patients who are currently taking Thyroid, USP from Lot 504950, which is being recalled, should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription.
- Consumers with questions about the recall can contact Vitruvias Therapeutics, Inc. by email at safety@
vitruvias.com or by phone at (256) 239-9373 Monday through Friday from 9 a.m. to 5 p.m. CT. - Contact your physician or healthcare provider if you have experienced any problems that may be related to taking or using this drug product.
Is yours affected?
Match the lot code, best-by or expiration date and NDC listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Thyroid Tablets, USP 30 mg
- NDC
- 69680-166-00
- Lot code
- 504950
- Best-by or expiration date
- 9/30/2026
- Distribution
- 1/31/2025
- Units released
- 3,655
- Units sold
- 1955
- Last distribution date
- 9/30/2025
Recall details
- Company began the recall
- Sold in
US Nationwide.
- Company
- VITRUVIAS THERAPEUTICS INCAuburn, Alabama
- Hazard
- Wrong drug strength
- Risk
High risk
There is a reasonable chance that taking it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 99709
- Recall number
- D-0866-2026
- Quantity recalled
- 1955 bottles
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall · Announced by the company
Listed on Recall Canary
Added to FDA's Enforcement Report
Classified by FDA
In FDA's weekly enforcement report
Summary updated
